Skip to main content

ORBIMED ADVISORS LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1055951 New York, NY

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
10,570,300
+77.2% QoQ
Ownership
4.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
3 quarters on record
Voting authority Sole 45% Shared 0% None 55%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $67,146,504 across 4 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-03-31 10,570,300
2025-12-31 5,965,498
2024-03-31 13,708,731